Drug
Alxn1840
Alxn1840: highest development phase Phase 3, developed by Alexion. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALXN1840 NCT05047523 | Phase 3 | Wilson Disease |
| ALXN1840 NCT05319899 | Phase 1 | Healthy |
Latest
No recent events.
Follow Alxn1840 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.